Science Synapse AB
Software that makes scientific publishing easier to trust
We build and operate our own platforms for the research community. JournalLens helps researchers evaluate academic journals on evidence. JournAI helps authors find the right journal for their manuscript.
Our products
Two platforms, built and operated in house
Both products are developed by Science Synapse AB and run on our own infrastructure. Each has its own live platform that you can use today.
JournalLens
Live platformKnow which journals you can trust
JournalLens is a platform that helps researchers and institutions evaluate academic journals. It combines quality metrics, a credibility score and personalised recommendations so that publishing decisions are made on evidence rather than reputation alone.
The JournalLens index alone holds more than 224,000 academic journals, and a growing number of outlets are predatory or low quality. Choosing where to publish is high stakes and the information needed to choose well is scattered, inconsistent and often behind paywalls.
Free account, no card required
JournAI
BetaAI assisted journal discovery
JournAI helps authors find the right journal for a specific manuscript. It analyses the work itself and suggests suitable venues, rather than relying on the author already knowing the landscape.
Matching a manuscript to a suitable journal is slow, manual and biased towards journals the author already knows. Poor matching causes desk rejections and long delays in publication.
Free to try while in beta
What our platforms cover today
224,212
Academic journals indexed
70M+
Papers analysed
45,178
Publishers covered
189
Countries represented
244
Research fields classified
Why we build this
The problem we work on
Too many journals to judge
Our index alone holds more than 224,000 academic journals, and the signals needed to tell a credible one from a predatory one are scattered and inconsistent.
Publishing decisions are high stakes
A poor journal choice costs months of delay, wasted funding, and in the worst case damages a researcher record permanently.
The data exists, the tooling does not
Open bibliographic data is now abundant. What has been missing is software that turns it into a decision a working researcher can act on.
Contact
Get in touch
Questions about our platforms, or interested in working with us? Send a message and we will reply by email.
Connect on LinkedIn
Follow us for updatesAddress
Västra Vägen 19, 169 61 Solna, Sweden
Company
Science Synapse AB
Organisation number 559575-2667
VAT SE559575266701
Who we are
The founders
Science Synapse AB is a Swedish company registered in Solna, founded by two people with complementary backgrounds in scientific publishing, epidemiology and operations.
Omid Beiki
Co-Founder
Physician and epidemiologist, MD, PhD and MSc in Health Informatics. Board member of the World Association of Medical Editors and Academic Editor at PLOS ONE.
- MD, PhD, and MSc in Health Informatics
- Board of Directors, World Association of Medical Editors, since 2025
- Academic Editor, PLOS ONE, since 2017
- Affiliated Research Scientist, Karolinska Institutet, since 2012
- Founder and CEO, Pejouhan Co, 2000 to 2006
- Associate Director Epidemiologist, Cognizant, since 2016
- Editor-in-Chief, Basic and Clinical Cancer Research, 2015 to 2017
- Managing Editor, European Journal of Public Health, 2010 to 2011
Najmeh Karimi
Co-Founder
Responsible for operations and administration. MSc in Population Health, with a background in research project coordination and hands-on project management.
- MSc in Population Health
- Responsible for operations and administration at Science Synapse AB
- Research project follow-up and partner coordination at a research centre
- Site lead and elected workplace safety representative, Solna
- Programme supervisor and mentor, Solna stad